Work

Phase II study of pembrolizumab plus mifepristone in patients with advanced HER2-negative breast cancer.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.1095

Authors: Nan Chen, Elena Michaels, Poornima Saha, Murtuza M. Rampurwala, Olwen Mary Hahn, Frederick Matthew Howard, Gini F. Fleming, Theodore Karrison, Suzanne D. Conzen, Rita Nanda

Institutions: University of Chicago, Endeavor Health, University of Chicago Medical Center, The University of Texas Southwestern Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4379285737

Cites:

Cited by: 2

Related to: 10